Global breast imaging market was valued at $5.9 billion in 2025 and is growing at a CAGR of 9.3% during the forecast period (2026-2035). The global breast imaging market is witnessing a significant transformation as healthcare providers increasingly prioritize early detection and accurate diagnosis of breast cancer. Advanced imaging technologies, such as 3D mammography (tomosynthesis) and AI-assisted imaging, are enhancing diagnostic precision while reducing radiologist workload. There is a growing emphasis on personalized screening programs that tailor imaging frequency and techniques based on individual risk profiles. Portable and handheld imaging devices are expanding access in underserved regions, supporting broader population coverage. Additionally, integration of contrast-enhanced imaging and image-guided biopsy procedures is improving the detection of subtle and complex lesions. Government initiatives and awareness campaigns are further driving routine breast screening adoption. Overall, the market is evolving toward more accurate, efficient, and patient-centric imaging solutions.
Browse the full report description of “Breast Imaging Market Size, Share & Trends Analysis Report by Ionizing Breast Technologies (Analog Mammography, 3D Breast Tomosynthesis, Cone Beam Computed Tomography (CB-CT), Positron Emission Mammography (PEM), and Molecular Breast Imaging), By Non-Ionizing Breast Technologies (Breast MRI, Breast Ultrasound, Optical Imaging, and Breast Thermography), By Screening Method (Symptomatic Imaging and Asymptomatic Imaging) Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/breast-imaging-market
Advancement of 3D Mammography Driving Improved Breast Cancer Detection Rates
Advancement of 3D mammography, or digital breast tomosynthesis (DBT), is becoming a key driver in the breast imaging market by significantly improving cancer detection rates compared to traditional 2D mammography. By capturing multiple-layered images of breast tissue, 3D mammography reduces tissue overlap, allowing earlier and more accurate identification of tumors. This technology is increasingly adopted in hospitals, diagnostic centers, and specialty clinics, boosting market demand. Studies in 2024–2025 show that 3D mammography can detect up to 41–47% more cancers, particularly in women with dense breast tissue. The rising preference for DBT in screening programs is influencing purchasing decisions, vendor strategies, and overall market growth. As awareness of its diagnostic advantages spreads, 3D mammography is positioned as a central growth segment within the global breast imaging market.
Breast Imaging Market Key Players Driving Market Growth
The key players in the breast imaging market are Canon Medical Systems Corp., Fujifilm Holdings Corp., GE Healthcare, Hologic Inc., and Siemens Healthineers AG, among others. These companies are driving innovation and shaping the competitive landscape by focusing on technological advancements, expanding product portfolios, and enhancing imaging accuracy. They play a critical role in addressing the growing demand for early detection and personalized screening solutions, while also contributing to increased accessibility of breast imaging technologies globally. Strategic collaborations, research investments, and integration of AI and 3D imaging solutions are helping these players maintain leadership and meet evolving healthcare needs.
Market Coverage
Key questions addressed by the report.
Global Breast Imaging Market Report Segment
By Ionizing Breast Technologies
By Non-Ionizing Breast Technologies
By Screening Method
Global Breast Imaging Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/breast-imaging-market